IRIS
LIUZZI, Grazia Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.691
AS - Asia 3.229
EU - Europa 2.942
SA - Sud America 770
AF - Africa 219
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 14.860
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.565
SG - Singapore 1.323
IT - Italia 1.015
CN - Cina 814
BR - Brasile 632
HK - Hong Kong 421
SE - Svezia 388
DE - Germania 282
RU - Federazione Russa 258
FR - Francia 253
UA - Ucraina 250
FI - Finlandia 194
VN - Vietnam 167
GB - Regno Unito 123
IN - India 120
CI - Costa d'Avorio 118
BD - Bangladesh 93
CA - Canada 65
AR - Argentina 47
IQ - Iraq 43
TR - Turchia 38
ZA - Sudafrica 32
PK - Pakistan 31
BE - Belgio 28
NL - Olanda 28
CO - Colombia 25
MX - Messico 25
VE - Venezuela 22
ID - Indonesia 21
IE - Irlanda 21
PH - Filippine 21
PL - Polonia 21
MA - Marocco 19
ES - Italia 18
JP - Giappone 18
SA - Arabia Saudita 13
UZ - Uzbekistan 13
AT - Austria 12
EC - Ecuador 12
CL - Cile 11
IR - Iran 11
TN - Tunisia 10
ET - Etiopia 9
JO - Giordania 9
MY - Malesia 9
AE - Emirati Arabi Uniti 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
JM - Giamaica 8
OM - Oman 8
AU - Australia 7
LT - Lituania 7
PY - Paraguay 7
CR - Costa Rica 6
EG - Egitto 6
HN - Honduras 6
PS - Palestinian Territory 6
SN - Senegal 6
AZ - Azerbaigian 5
KE - Kenya 5
PE - Perù 5
BO - Bolivia 4
KR - Corea 4
LB - Libano 4
PT - Portogallo 4
RS - Serbia 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
GE - Georgia 3
HU - Ungheria 3
IL - Israele 3
KZ - Kazakistan 3
MD - Moldavia 3
NI - Nicaragua 3
NP - Nepal 3
PA - Panama 3
CH - Svizzera 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LV - Lettonia 2
MN - Mongolia 2
QA - Qatar 2
RO - Romania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
Totale 14.844
Salva come PNG Salva come JPEG
Città #
Woodbridge 672
Ashburn 666
Singapore 647
Fairfield 605
Chandler 604
Jacksonville 565
San Jose 537
Hong Kong 417
Houston 414
Milan 356
Ann Arbor 333
Nyköping 315
Wilmington 245
Seattle 244
Cambridge 227
Beijing 222
Rome 132
Lawrence 127
Roxbury 126
Abidjan 118
New York 118
Lauterbourg 117
Nanjing 110
Bari 107
Boardman 102
Marseille 99
Des Moines 79
Los Angeles 77
Dallas 58
Ho Chi Minh City 58
Inglewood 56
Brooklyn 54
São Paulo 53
Santa Clara 51
Helsinki 45
Munich 43
Princeton 39
Columbus 38
Buffalo 37
Jiaxing 37
Hanoi 35
Falkenstein 34
Shenyang 34
Council Bluffs 29
Nanchang 29
Turku 28
Moscow 27
San Diego 27
Brussels 26
Changsha 25
Guangzhou 25
London 25
Figino 24
Hebei 24
Chicago 23
Baghdad 22
Turin 22
Dublin 21
Shanghai 21
Denver 20
Belo Horizonte 19
Dhaka 19
Rio de Janeiro 19
Toronto 18
Amsterdam 17
Frankfurt am Main 17
Montreal 17
San Francisco 17
Tianjin 17
Warsaw 17
Chennai 16
Leawood 16
Leverano 16
Palermo 16
Da Nang 15
Dearborn 15
Orem 15
Spongano 15
Tokyo 15
Curitiba 14
Wuhan 14
Atlanta 13
Auburn Hills 13
Jakarta 13
Paris 13
Johannesburg 12
Lahore 12
Monmouth Junction 12
Mumbai 12
Pune 12
Tashkent 12
Caracas 11
Falls Church 11
Naples 11
Nuremberg 11
Augusta 10
Bologna 10
Campinas 10
New Delhi 10
Porto Alegre 10
Totale 10.033
Salva come PNG Salva come JPEG
Nome #
FAD synthase deficiency: a severe mitochondrial myopathy involving a secondary reduction of RFVT2 expression 195
Cytotoxicity Study on Luminescent Nanocrystals Containing Phospholipid Micelles in Primary Cultures of Rat Astrocytes 195
FAD synthesis and degradation in the nucleus create a local flavin cofactor pool 190
Inhibitory Effect of Aqueous Extracts from Marine Sponges on the Activity and Expression of Gelatinases A (MMP-2) and B (MMP-9) in Rat Astrocyte Cultures 185
Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta 182
Comparative analysis of protein profiles of aqueous extracts from marine sponges and assessment of cytotoxicity on different mammalian cell types 174
FAD synthase deficiency: a severe mitochondrial myopathy searching for novel therapeutic strategies 160
A thermodynamic and structural study of myelin basic protein in lipid membrane models 157
Biological variations in a long-term ex situ cultivation: a Mediterranean demosponge as model system 153
Apolipoprotein(a) inhibits lipopolysaccharide-induced IL-6 secretion in human astrocytoma cell line by interfering with lipopolysaccharide signaling 153
A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains 150
Antiretroviral Treatment Modulates The Release Of Matrix Metalloproteinases In Rat Astrocyte Cell Cultures 149
BLOOD MMP-9 AND SICAM-1 AS MARKERS OF RIFN-B TREATMENT EFFICACY IN RELAPSING-REMITTING MS 145
Structure-Dependent Inhibition of Gelatinases by Dietary Antioxidants in Rat Astrocytes and Sera of Multiple Sclerosis Patients 145
Liver fibrosis in HCV monoinfected and HIV/HCV coinfected patients: Dysregulation of matrix metalloproteinases (MMPs) and their tissue inhibitors TIMPs and effect of HCV protease inhibitors 145
Aquaporin-4-containing astrocytes sustain a temperature- and mercury-insensitive swelling in vitro 144
Native Myelin Proteins and Myelin Assembly in the Central Nervous System 140
Antiretroviral therapy inhibits matrix metalloproteinase-9 from blood mononuclear cells of HIV-infected patients 138
Coordinated inhibition of Matrix Metalloproteinase-9 and Urokinase Plasminogen activator by immunomodulant therapies in peripheral blood Mononuclear Cells from MS patients 137
Autoimmune Myelofibrosis: report of three cases and review of the literature 137
Antiretroviral treatment modulates the release of matrix metalloproteinases in rat astrocyte cell cultures 136
Anti-endothelial cell antibodies (AECA) in a patient wiyh Takayasu’s arteritis. In: Pathogenesis and immunotherapy of autoimmune diseases. Final program and abstract book 133
Antibodies specific for the lipid-bound form of myelin basic protein during experimental autoimmune encephalomyelitis 133
Identification of water-soluble proteases in myelin preparations 129
Cerebrospinal fluid myelin basic protein as predictive marker of demyelination in AIDS dementia complex 128
Expression of myelin basic protein (MBP) epitopes in human non-neural cells revealed by two anti-MBP IgM monoclonal antibodies 128
Recombinant arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 128
Matrix metalloproteinase dysregulation in HIV infection: implications for therapeutic strategies 126
Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain 125
In Vitro Downregulation of Matrix Metalloproteinase-9 in Rat Glial Cells by CCR5 Antagonist Maraviroc: Therapeutic Implication for HIV Brain Infection. 125
Dysregulation of MMPs and TIMPs in HCV in monoinfected and HCV/HIV coinfected patients. Positive effect of HCV protease inhibitor treatment. 124
ADHESION MOLECULES AND MATRIX METALLOPROTEINASES IN MS: EFFECTS INDUCED BY INTERFERON BETA 122
T-cell response to myelin basic protein and lipid-bound myelin basic protein in patients with multiple sclerosis and healthy donors 121
Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases 121
Marine pharmacology: Therapeutic targeting of matrix metalloproteinases in neuroinflammation 119
Crystals of P2 myelin protein in lipid-bound form 118
New Diagnostic and Therapeutic Options for the Treatment of Multiple Sclerosis 118
Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants. 118
Different recognition by clostripain of myelin basic protein in the lipid-free and lipid-bound forms 117
Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes 117
Luminescent PLGA Nanoparticles for Delivery of Darunavir to the Brain and Inhibition of Matrix Metalloproteinase-9, a Relevant Therapeutic Target of HIV-Associated Neurological Disorders 113
In vitro effect of antiretroviral drugs on cultured primary astrocytes: analysis of neurotoxicity and matrix metalloproteinase inhibition 110
Detection of cerebrospinal fluid antibodies against myelin basic protein in patients with AIDS dementia complex 110
Assessment of cell toxicity and matrix metalloproteinase-9 expression by antiretroviral drugs in cultured primary astrocytes. 110
Luminescent Polymeric Nanovectors Loaded with Darunavir for Treatment of HIV-Associated Neurological Diseases 110
May diet and dietary supplements improve the wellness of multiple sclerosis patients? A molecular approach. 109
Lipoprotein(a) in the cerebrospinal fluid of neurological patients with blood-cerebrospinal fluid barrier dysfunction 109
Bioisosteric replacement based on 1,2,4-oxadiazoles in the discovery of 1H-indazole-bearing neuroprotective MAO B inhibitors 108
Detection of MMP-9 sialylated isotypes in sera of patients with relapsing/remitting multiple sclerosis 107
Retrograde response to mitochondrial dysfunctions associated to LOF variations in FLAD1 exon 2: unraveling the importance of RFVT2 106
Structure-based design of multitargeting ChEs-MAO B inhibitors based on phenyl ring bioisosteres: AChE/BChE selectivity switch and drug-like characterization 106
Purification of bovine P2 myelin protein with bound lipids 106
Neuroprotective effect of resveratrol egainst Manganese-induced Matrix Matalloproteinases-9 and oxidative stress in a “vivo” model of neurotoxicity. 105
Decreased levels of serum Gelatinase B in MS patients treated with rIFN-beta-1b 105
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients 105
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 103
Meccanismo molecolare di “Swelling” in astrociti in coltura 103
The different forms of PNS myelin P0 protein within and outside lipid rafts 102
Aumento dell’attività della Gelatinasi B nel liquor di pazienti HIV-positivi con malattie neurologiche del Sistema Nervoso Centrale 102
Lipoprotein(a) presence in the cerebrospinal fluid of patients with neurologic disorders 102
Inhibitory Effect of Polyunsaturated Fatty Acids on MMP-9 Release from Microglial Cells-Implications for Complementary Multiple Sclerosis Treatment 102
In vitro effect of antiretroviral drugs on cell toxicity and matrix metalloproteinase-9 inhibition in cultured primary astrocytes. 101
Laminar order within Langmuir-Blodgett multilayers from phospholipid and myelin basic protein: a neutron reflectivity study 101
Inhibition of aquaporin-4 expression in astrocytes by RNAi determines alteration in cell morphology, growth, and water transport and induces changes in ischemia-related genes 101
Meccanismi di demielinizzazione in pazienti con neuroAIDS 100
Autoimmune bone marrow fibrosis: a distinct clinicopathological entity 100
Impact of lead neurotoxicity on gelatinase production in THP-1 cells. effects of antioxidants and therapeutical implication for the treatment of cns diseases 100
Oral administration of nucleotides in calves: Effects on oxidative status, immune response, and intestinal mucosa development 100
INTERFERON-beta INHIBITS THE EXPRESSION OF METALLOPROTEINASES IN RAT GLIAL CELL CULTURES: IMPLICATIONS FOR MULTIPLE SCLEROSIS PATHOGENESIS AND TREATMENT 99
CHANGES OF SERUM ICAM-1 AND MMP-9 INDUCED BY RIFNB-1B TREATMENT IN RELAPSING-REMITTING MS 99
Detection of serum levels and intrathecal synthesis of matrix metallo proteinase-9 in relapsing-remitting multiple sclerosis 98
In vitro downregulation of matrix metalloproteinase-9 in rat astrocytes by CCR5 antagonist maraviroc: potential therapeutical implication for HIV-associated neurological disease. 96
Bioassay-guided identification of bioactive protein compounds from the Mediterranean demosponge Tethya meloni 96
Novel 6-hydroxybenzothiazol-2-carboxamides as potent and selective monoamine oxidase B inhibitors endowed with neuroprotective activity 96
CEREBROSPINAL FLUID MARKERS FOR THE MONITORING OF AIDS DEMENTIA COMPLEX SEVERITY: USEFULNESS OF ANTI-MYELIN BASIC PROTEIN ANTIBODY DETECTION 95
Increased Gelatinase B Activity in the CSF of Patients with HIV-Associated Neurological Diseases 95
Determinazione degli Anticorpi Liquorali Anti-MBP per la Diagnosi di Danno Mielinico in Pazienti con AIDS Dementia Complex 94
Interferon-beta Treatment Inhibits Calpain Expression In Rat Astrocytes. Implications For Ms Pathogenesis And Treatment. 94
Impact of manganese neurotoxicity on gelatinase production in rat primary astrocytes. Effect of resveratrol and therapeutical implications for the treatment of CNS diseases. 93
Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases 91
Anti-HIV drugs decrease the expression of matrix metalloproteinases in astrocytes and microglia 91
Induction of experimental autoimmune encephalomyelitis in rats and immune response to myelin basic protein in lipid-bound form 91
null 91
null 90
CNS Myelin Proteins in Lipid-Bound Native Form as Tools for Study, Detection and Treatment of Multiple Sclerosis 90
Matrix Metalloproteinases in CNS Inflammation. 89
Ruolo delle proteasi nell’induzione e nella patogenesi della sclerosi multipla 89
Il ruolo delle proteasi nell’induzione e nella patogenesi della Sclerosi Multipla 88
Release of myelin basic protein-degrading proteolytic activity from microglia and macrophages after infection with Theiler's murine encephalomyelitis virus: comparison between susceptible and resistant mice 88
Intrathecal synthesis of matrix metalloproteinase (MMP)-9 in patients with relapsing-remitting (RR) multiple sclerosis (MS) 87
CHANGES OF SERUM SOLUBLE ICAM-1 AND MATRIX METALLOPROTEINASE-9 DURING INTERFERON BETA-1B TREATMENT IN RR MS 87
null 87
Evaluation of Cell Toxicity and Matrix Metalloproteinase-9 Inhibition by combination of Antiretroviral Drugs in Cultured Primary Astrocytes. Implication for the treatment of neuroAIDS. 87
Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis 87
In vitro cell toxicity and Matrix Metalloproteinase-9 inhibition by antiretroviral drugs in cultured primary astrocytes 86
Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins 86
Demyelination and cerebral toxoplasmosis in HIV-infected patients 85
Follow-up of myelin damage in HIV-associated cryptococcal meningitis. First evidence of anti-myelin basic protein antibodies in the cerebrospinal fluid 84
Matrix metalloproteinases in demyelinating diseases: targets for treatment. 84
Decreased levels of serum gelatinase B in MS patients during the treatment with rIFN-beta-1b 83
Totale 11.492
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.391
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.391
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022805 24 116 6 24 33 51 32 47 57 55 158 202
2022/20231.675 197 138 106 170 216 213 13 187 347 36 25 27
2023/2024551 44 97 23 120 46 118 7 6 6 14 10 60
2024/20252.239 130 41 197 60 66 134 183 181 96 104 297 750
2025/20265.162 678 269 300 493 515 264 504 120 604 497 228 690
2026/2027116 116 0 0 0 0 0 0 0 0 0 0 0
Totale 15.065